When should apixaban be discontinued prior to arteriovenous fistula creation?

When to Hold Apixaban Prior to AV Fistula Creation

Hold apixaban for 48 hours (2 days) before arteriovenous fistula creation.

Rationale Based on Bleeding Risk Classification

AV fistula creation is classified as a high bleeding risk procedure because:

• Surgical hemostasis cannot be easily controlled in vascular access surgery
• The procedure involves direct manipulation of major vessels
• Bleeding complications can compromise fistula maturation and patency

Specific Timing Recommendations

For patients with normal renal function (CrCl >25 mL/min):

• Stop apixaban 2 full days before surgery 1, 2
• This means if surgery is scheduled for Monday morning, the last dose should be Saturday morning (for twice-daily dosing)

The FDA label explicitly states: "Apixaban tablets should be discontinued at least 48 hours prior to elective surgery or invasive procedures with a moderate or high risk of unacceptable or clinically significant bleeding" 2

This recommendation is consistently supported across multiple high-quality guidelines:

• The 2024 ACC/AHA/ACCP/HRS guidelines specify 2 days for high bleeding risk procedures 1
• The 2017 French GIHP guidelines recommend 3 days for high hemorrhagic risk procedures when CrCl >30 mL/min 3
• The 2014 Canadian guidelines suggest 2-3 days for intermediate or high bleeding risk 4

Critical Considerations for Renal Function

If the patient has impaired renal function:

• The interruption period should be extended because apixaban has 25% renal clearance
• For CrCl 25-50 mL/min: Consider holding for an additional 1-2 days (total 3-4 days) 1
• Always check recent creatinine clearance before scheduling

What NOT to Do

Do not use bridging anticoagulation 3, 5

• Bridging with heparin or LMWH is not recommended for DOAC interruption
• This differs from warfarin management and increases bleeding risk without reducing thrombotic events

Do not continue apixaban through the procedure

• While some low-risk procedures can be done on anticoagulation, vascular access surgery requires complete interruption
• Recent evidence shows continuation increases bleeding risk in vascular procedures 6

When to Restart After Surgery

Resume apixaban 48-72 hours post-operatively once adequate hemostasis is established 4, 2

• For AV fistula creation, err on the side of waiting the full 72 hours given the importance of preventing hematoma formation that could compromise fistula maturation
• Ensure there is no ongoing bleeding or surgical contraindication before restarting

Special Context for AV Fistula Patients

Emerging evidence suggests apixaban may actually reduce early anastomotic stenosis and improve fistula patency when used after creation 7. However, this benefit applies to the post-operative period, not the peri-operative window. The key is balancing:

• Pre-operative: Adequate drug clearance to prevent surgical bleeding
• Post-operative: Timely resumption to potentially reduce intimal hyperplasia and thrombosis

Common Pitfalls to Avoid

1. Don't use the 24-hour window meant for low bleeding risk procedures - AV fistula creation is definitively high-risk
2. Don't forget to assess renal function - many dialysis patients have severely impaired clearance requiring longer interruption
3. Don't bridge with heparin - this outdated practice increases bleeding without benefit for DOACs
4. Don't restart too early - premature resumption can cause hematoma formation that compromises fistula maturation